Bank of New York Mellon’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,554
Closed -$13K 4759
2022
Q1
$13K Hold
1,554
﹤0.01% 4633
2021
Q4
$21K Hold
1,554
﹤0.01% 4582
2021
Q3
$68K Hold
1,554
﹤0.01% 4387
2021
Q2
$65K Sell
1,554
-9,938
-86% -$416K ﹤0.01% 4284
2021
Q1
$556K Sell
11,492
-142
-1% -$6.87K ﹤0.01% 3626
2020
Q4
$1.14M Sell
11,634
-664
-5% -$65.2K ﹤0.01% 3184
2020
Q3
$849K Sell
12,298
-124
-1% -$8.56K ﹤0.01% 3216
2020
Q2
$1.31M Buy
12,422
+1,674
+16% +$177K ﹤0.01% 2945
2020
Q1
$954K Buy
10,748
+1,592
+17% +$141K ﹤0.01% 3016
2019
Q4
$1.05M Buy
9,156
+814
+10% +$93K ﹤0.01% 3224
2019
Q3
$516K Buy
8,342
+1,537
+23% +$95.1K ﹤0.01% 3519
2019
Q2
$531K Buy
6,805
+374
+6% +$29.2K ﹤0.01% 3565
2019
Q1
$866K Buy
6,431
+75
+1% +$10.1K ﹤0.01% 3275
2018
Q4
$510K Sell
6,356
-1,935
-23% -$155K ﹤0.01% 3465
2018
Q3
$871K Buy
8,291
+192
+2% +$20.2K ﹤0.01% 3347
2018
Q2
$810K Buy
8,099
+1,217
+18% +$122K ﹤0.01% 3364
2018
Q1
$867K Buy
6,882
+248
+4% +$31.2K ﹤0.01% 3290
2017
Q4
$1.11M Buy
6,634
+1,134
+21% +$189K ﹤0.01% 3178
2017
Q3
$1.73M Buy
5,500
+95
+2% +$29.9K ﹤0.01% 2922
2017
Q2
$1.61M Buy
5,405
+3,771
+231% +$1.12M ﹤0.01% 2974
2017
Q1
$377K Buy
1,634
+243
+17% +$56.1K ﹤0.01% 3666
2016
Q4
$90K Buy
1,391
+548
+65% +$35.5K ﹤0.01% 4042
2016
Q3
$55K Sell
843
-151
-15% -$9.85K ﹤0.01% 4128
2016
Q2
$74K Sell
994
-1,292
-57% -$96.2K ﹤0.01% 4113
2016
Q1
$260K Sell
2,286
-285
-11% -$32.4K ﹤0.01% 3697
2015
Q4
$394K Buy
2,571
+899
+54% +$138K ﹤0.01% 3606
2015
Q3
$181K Sell
1,672
-387
-19% -$41.9K ﹤0.01% 3897
2015
Q2
$294K Buy
2,059
+492
+31% +$70.3K ﹤0.01% 3783
2015
Q1
$515K Buy
1,567
+75
+5% +$24.6K ﹤0.01% 3592
2014
Q4
$603K Buy
+1,492
New +$603K ﹤0.01% 3538